Global NK Cells Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Market Overview
The global NK Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The NK Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
NK Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, NK Cells market has been segmented into
Mogamulizumab
Lorvotuzumab Mertansine
Others
By Application, NK Cells has been segmented into:
Cancer
Cardiovascular Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NK Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level NK Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NK Cells market.
The report offers in-depth assessment of the growth and other aspects of the NK Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and NK Cells Market Share Analysis
NK Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NK Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NK Cells sales, revenue and market share for each player covered in this report.
The major players covered in NK Cells are:
Chipscreen Biosciences (China)
Bristol-Myers Squibb (USA)
Innate Pharma SA (France)
Affimed NV (Netherlands)
NantKwest Inc. (USA)
Altor BioScience Corporation (USA)
Sorrento Therapeutics Inc. (USA)
Takeda Pharmaceutical (Japan)
NKT Therapeutics (USA)
Among other players domestic and global, NK Cells market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe NK Cells product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of NK Cells, with price, sales, revenue and global market share of NK Cells in 2018 and 2019.
Chapter 3, the NK Cells competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NK Cells breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, NK Cells market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe NK Cells sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 NK Cells Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global NK Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global NK Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Overview of Global NK Cells Market
1.4.1 Global NK Cells Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Chipscreen Biosciences (China)
2.1.1 Chipscreen Biosciences (China) Details
2.1.2 Chipscreen Biosciences (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Chipscreen Biosciences (China) SWOT Analysis
2.1.4 Chipscreen Biosciences (China) Product and Services
2.1.5 Chipscreen Biosciences (China) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb (USA)
2.2.1 Bristol-Myers Squibb (USA) Details
2.2.2 Bristol-Myers Squibb (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb (USA) SWOT Analysis
2.2.4 Bristol-Myers Squibb (USA) Product and Services
2.2.5 Bristol-Myers Squibb (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Innate Pharma SA (France)
2.3.1 Innate Pharma SA (France) Details
2.3.2 Innate Pharma SA (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Innate Pharma SA (France) SWOT Analysis
2.3.4 Innate Pharma SA (France) Product and Services
2.3.5 Innate Pharma SA (France) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Affimed NV (Netherlands)
2.4.1 Affimed NV (Netherlands) Details
2.4.2 Affimed NV (Netherlands) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Affimed NV (Netherlands) SWOT Analysis
2.4.4 Affimed NV (Netherlands) Product and Services
2.4.5 Affimed NV (Netherlands) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 NantKwest Inc. (USA)
2.5.1 NantKwest Inc. (USA) Details
2.5.2 NantKwest Inc. (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 NantKwest Inc. (USA) SWOT Analysis
2.5.4 NantKwest Inc. (USA) Product and Services
2.5.5 NantKwest Inc. (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Altor BioScience Corporation (USA)
2.6.1 Altor BioScience Corporation (USA) Details
2.6.2 Altor BioScience Corporation (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Altor BioScience Corporation (USA) SWOT Analysis
2.6.4 Altor BioScience Corporation (USA) Product and Services
2.6.5 Altor BioScience Corporation (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sorrento Therapeutics Inc. (USA)
2.7.1 Sorrento Therapeutics Inc. (USA) Details
2.7.2 Sorrento Therapeutics Inc. (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sorrento Therapeutics Inc. (USA) SWOT Analysis
2.7.4 Sorrento Therapeutics Inc. (USA) Product and Services
2.7.5 Sorrento Therapeutics Inc. (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Takeda Pharmaceutical (Japan)
2.8.1 Takeda Pharmaceutical (Japan) Details
2.8.2 Takeda Pharmaceutical (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Takeda Pharmaceutical (Japan) SWOT Analysis
2.8.4 Takeda Pharmaceutical (Japan) Product and Services
2.8.5 Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 NKT Therapeutics (USA)
2.9.1 NKT Therapeutics (USA) Details
2.9.2 NKT Therapeutics (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 NKT Therapeutics (USA) SWOT Analysis
2.9.4 NKT Therapeutics (USA) Product and Services
2.9.5 NKT Therapeutics (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global NK Cells Sales and Market Share by Manufacturer (2018-2019)
3.2 Global NK Cells Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 NK Cells Manufacturer Market Share in 2019
3.3.2 Top 6 NK Cells Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global NK Cells Sales, Revenue and Market Share by Regions
4.1.1 Global NK Cells Sales and Market Share by Regions (2015-2020)
4.1.2 Global NK Cells Revenue and Market Share by Regions (2015-2020)
4.2 North America NK Cells Sales and Growth Rate (2015-2020)
4.3 Europe NK Cells Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific NK Cells Sales and Growth Rate (2015-2020)
4.5 South America NK Cells Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa NK Cells Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America NK Cells Sales, Revenue and Market Share by Country
5.1.1 North America NK Cells Sales and Market Share by Country (2015-2020)
5.1.2 North America NK Cells Revenue and Market Share by Country (2015-2020)
5.2 United States NK Cells Sales and Growth Rate (2015-2020)
5.3 Canada NK Cells Sales and Growth Rate (2015-2020)
5.4 Mexico NK Cells Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe NK Cells Sales, Revenue and Market Share by Country
6.1.1 Europe NK Cells Sales and Market Share by Country (2015-2020)
6.1.2 Europe NK Cells Revenue and Market Share by Country (2015-2020)
6.2 Germany NK Cells Sales and Growth Rate (2015-2020)
6.3 UK NK Cells Sales and Growth Rate (2015-2020)
6.4 France NK Cells Sales and Growth Rate (2015-2020)
6.5 Russia NK Cells Sales and Growth Rate (2015-2020)
6.6 Italy NK Cells Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific NK Cells Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific NK Cells Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific NK Cells Revenue and Market Share by Regions (2015-2020)
7.2 China NK Cells Sales and Growth Rate (2015-2020)
7.3 Japan NK Cells Sales and Growth Rate (2015-2020)
7.4 Korea NK Cells Sales and Growth Rate (2015-2020)
7.5 India NK Cells Sales and Growth Rate (2015-2020)
7.6 Southeast Asia NK Cells Sales and Growth Rate (2015-2020)
7.7 Australia NK Cells Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America NK Cells Sales, Revenue and Market Share by Country
8.1.1 South America NK Cells Sales and Market Share by Country (2015-2020)
8.1.2 South America NK Cells Revenue and Market Share by Country (2015-2020)
8.2 Brazil NK Cells Sales and Growth Rate (2015-2020)
8.3 Argentina NK Cells Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa NK Cells Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa NK Cells Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa NK Cells Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia NK Cells Sales and Growth Rate (2015-2020)
9.3 Turkey NK Cells Sales and Growth Rate (2015-2020)
9.4 Egypt NK Cells Sales and Growth Rate (2015-2020)
9.5 South Africa NK Cells Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global NK Cells Sales and Market Share by Type (2015-2020)
10.2 Global NK Cells Revenue and Market Share by Type (2015-2020)
10.3 Global NK Cells Price by Type (2015-2020)
11 Global NK Cells Market Segment by Application
11.1 Global NK Cells Sales Market Share by Application (2015-2020)
11.2 Global NK Cells Revenue Market Share by Application (2015-2020)
11.3 Global NK Cells Price by Application (2015-2020)
12 Market Forecast
12.1 Global NK Cells Sales, Revenue and Growth Rate (2021-2025)
12.2 NK Cells Market Forecast by Regions (2021-2025)
12.2.1 North America NK Cells Market Forecast (2021-2025)
12.2.2 Europe NK Cells Market Forecast (2021-2025)
12.2.3 Asia-Pacific NK Cells Market Forecast (2021-2025)
12.2.4 South America NK Cells Market Forecast (2021-2025)
12.2.5 Middle East & Africa NK Cells Market Forecast (2021-2025)
12.3 NK Cells Market Forecast by Type (2021-2025)
12.3.1 Global NK Cells Sales Forecast by Type (2021-2025)
12.3.2 Global NK Cells Market Share Forecast by Type (2021-2025)
12.4 NK Cells Market Forecast by Application (2021-2025)
12.4.1 Global NK Cells Sales Forecast by Application (2021-2025)
12.4.2 Global NK Cells Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global NK Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NK Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NK Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Chipscreen Biosciences (China) Basic Information, Manufacturing Base and Competitors
Table 8. Chipscreen Biosciences (China) NK Cells Major Business
Table 9. Chipscreen Biosciences (China) NK Cells Total Revenue (USD Million) (2017-2018)
Table 10. Chipscreen Biosciences (China) SWOT Analysis
Table 11. Chipscreen Biosciences (China) NK Cells Product and Services
Table 12. Chipscreen Biosciences (China) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb (USA) Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb (USA) NK Cells Major Business
Table 15. Bristol-Myers Squibb (USA) NK Cells Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb (USA) SWOT Analysis
Table 17. Bristol-Myers Squibb (USA) NK Cells Product and Services
Table 18. Bristol-Myers Squibb (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Innate Pharma SA (France) Basic Information, Manufacturing Base and Competitors
Table 20. Innate Pharma SA (France) NK Cells Major Business
Table 21. Innate Pharma SA (France) NK Cells Total Revenue (USD Million) (2017-2018)
Table 22. Innate Pharma SA (France) SWOT Analysis
Table 23. Innate Pharma SA (France) NK Cells Product and Services
Table 24. Innate Pharma SA (France) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Affimed NV (Netherlands) Basic Information, Manufacturing Base and Competitors
Table 26. Affimed NV (Netherlands) NK Cells Major Business
Table 27. Affimed NV (Netherlands) NK Cells Total Revenue (USD Million) (2017-2018)
Table 28. Affimed NV (Netherlands) SWOT Analysis
Table 29. Affimed NV (Netherlands) NK Cells Product and Services
Table 30. Affimed NV (Netherlands) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. NantKwest Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 32. NantKwest Inc. (USA) NK Cells Major Business
Table 33. NantKwest Inc. (USA) NK Cells Total Revenue (USD Million) (2017-2018)
Table 34. NantKwest Inc. (USA) SWOT Analysis
Table 35. NantKwest Inc. (USA) NK Cells Product and Services
Table 36. NantKwest Inc. (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Altor BioScience Corporation (USA) Basic Information, Manufacturing Base and Competitors
Table 38. Altor BioScience Corporation (USA) NK Cells Major Business
Table 39. Altor BioScience Corporation (USA) NK Cells Total Revenue (USD Million) (2017-2018)
Table 40. Altor BioScience Corporation (USA) SWOT Analysis
Table 41. Altor BioScience Corporation (USA) NK Cells Product and Services
Table 42. Altor BioScience Corporation (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sorrento Therapeutics Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 44. Sorrento Therapeutics Inc. (USA) NK Cells Major Business
Table 45. Sorrento Therapeutics Inc. (USA) NK Cells Total Revenue (USD Million) (2017-2018)
Table 46. Sorrento Therapeutics Inc. (USA) SWOT Analysis
Table 47. Sorrento Therapeutics Inc. (USA) NK Cells Product and Services
Table 48. Sorrento Therapeutics Inc. (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base and Competitors
Table 50. Takeda Pharmaceutical (Japan) NK Cells Major Business
Table 51. Takeda Pharmaceutical (Japan) NK Cells Total Revenue (USD Million) (2017-2018)
Table 52. Takeda Pharmaceutical (Japan) SWOT Analysis
Table 53. Takeda Pharmaceutical (Japan) NK Cells Product and Services
Table 54. Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. NKT Therapeutics (USA) Basic Information, Manufacturing Base and Competitors
Table 56. NKT Therapeutics (USA) NK Cells Major Business
Table 57. NKT Therapeutics (USA) NK Cells Total Revenue (USD Million) (2017-2018)
Table 58. NKT Therapeutics (USA) SWOT Analysis
Table 59. NKT Therapeutics (USA) NK Cells Product and Services
Table 60. NKT Therapeutics (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global NK Cells Sales by Manufacturer (2018-2019) (MT)
Table 62. Global NK Cells Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global NK Cells Sales by Regions (2015-2020) (MT)
Table 64. Global NK Cells Sales Market Share by Regions (2015-2020)
Table 65. Global NK Cells Revenue by Regions (2015-2020) (USD Million)
Table 66. North America NK Cells Sales by Countries (2015-2020) (MT)
Table 67. North America NK Cells Sales Market Share by Countries (2015-2020)
Table 68. North America NK Cells Revenue by Countries (2015-2020) (USD Million)
Table 69. North America NK Cells Revenue Market Share by Countries (2015-2020)
Table 70. Europe NK Cells Sales by Countries (2015-2020) (MT)
Table 71. Europe NK Cells Sales Market Share by Countries (2015-2020)
Table 72. Europe NK Cells Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific NK Cells Sales by Regions (2015-2020) (MT)
Table 74. Asia-Pacific NK Cells Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific NK Cells Revenue by Regions (2015-2020) (USD Million)
Table 76. South America NK Cells Sales by Countries (2015-2020) (MT)
Table 77. South America NK Cells Sales Market Share by Countries (2015-2020)
Table 78. South America NK Cells Revenue by Countries (2015-2020) (USD Million)
Table 79. South America NK Cells Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa NK Cells Sales by Countries (2015-2020) (MT)
Table 81. Middle East & Africa NK Cells Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa NK Cells Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa NK Cells Revenue Market Share by Countries (2015-2020)
Table 84. Global NK Cells Sales by Type (2015-2020) (MT)
Table 85. Global NK Cells Sales Share by Type (2015-2020)
Table 86. Global NK Cells Revenue by Type (2015-2020) (USD Million)
Table 87. Global NK Cells Revenue Share by Type (2015-2020)
Table 88. Global NK Cells Sales by Application (2015-2020) (MT)
Table 89. Global NK Cells Sales Share by Application (2015-2020)
Table 90. Global NK Cells Sales Forecast by Regions (2021-2025) (MT)
Table 91. Global NK Cells Market Share Forecast by Regions (2021-2025)
Table 92. Global NK Cells Sales Forecast by Type (2021-2025) (MT)
Table 93. Global NK Cells Market Share Forecast by Type (2021-2025)
Table 94. Global NK Cells Sales Forecast by Application (2021-2025)
Table 95. Global NK Cells Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. NK Cells Picture
Figure 2. Global Sales Market Share of NK Cells by Type in 2019
Figure 3. Mogamulizumab Picture
Figure 4. Lorvotuzumab Mertansine Picture
Figure 5. Others Picture
Figure 6. NK Cells Sales Market Share by Application in 2018
Figure 7. Cancer Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Others Picture
Figure 10. Global NK Cells Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia NK Cells Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey NK Cells Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global NK Cells Sales Market Share by Manufacturer in 2019
Figure 31. Global NK Cells Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 NK Cells Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 NK Cells Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global NK Cells Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global NK Cells Revenue Market Share by Regions (2015-2020)
Figure 38. Global NK Cells Revenue Market Share by Regions in 2018
Figure 39. North America NK Cells Sales and Growth Rate (2015-2020)
Figure 40. Europe NK Cells Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific NK Cells Sales and Growth Rate (2015-2020)
Figure 42. South America NK Cells Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa NK Cells Sales and Growth Rate (2015-2020)
Figure 44. North America NK Cells Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America NK Cells Sales Market Share by Countries (2015-2020)
Figure 46. North America NK Cells Sales Market Share by Countries in 2018
Figure 47. North America NK Cells Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America NK Cells Revenue Market Share by Countries in 2018
Figure 49. United States NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe NK Cells Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe NK Cells Revenue Market Share by Countries (2015-2020)
Figure 54. Europe NK Cells Revenue Market Share by Countries in 2019
Figure 55. Germany NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 57. France NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific NK Cells Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific NK Cells Sales Market Share by Regions 2019
Figure 62. Asia-Pacific NK Cells Revenue Market Share by Regions 2019
Figure 63. China NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 66. India NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America NK Cells Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America NK Cells Sales Market Share by Countries in 2019
Figure 70. South America NK Cells Revenue Market Share by Countries in 2019
Figure 71. Brazil NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa NK Cells Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa NK Cells Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa NK Cells Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa NK Cells Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa NK Cells Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global NK Cells Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global NK Cells Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales NK Cells Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales NK Cells Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales NK Cells Market Forecast (2021-2025) (MT)
Figure 86. South America Sales NK Cells Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales NK Cells Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Chipscreen Biosciences (China)
Bristol-Myers Squibb (USA)
Innate Pharma SA (France)
Affimed NV (Netherlands)
NantKwest Inc. (USA)
Altor BioScience Corporation (USA)
Sorrento Therapeutics Inc. (USA)
Takeda Pharmaceutical (Japan)
NKT Therapeutics (USA)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets